BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30784076)

  • 1. SNX9 determines the surface levels of integrin β1 in vascular endothelial cells: Implication in poor prognosis of human colorectal cancers overexpressing SNX9.
    Tanigawa K; Maekawa M; Kiyoi T; Nakayama J; Kitazawa R; Kitazawa S; Semba K; Taguchi T; Akita S; Yoshida M; Ishimaru K; Watanabe Y; Higashiyama S
    J Cell Physiol; 2019 Aug; 234(10):17280-17294. PubMed ID: 30784076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sorting nexin 9 (SNX9) regulates levels of the transmembrane ADAM9 at the cell surface.
    Mygind KJ; Störiko T; Freiberg ML; Samsøe-Petersen J; Schwarz J; Andersen OM; Kveiborg M
    J Biol Chem; 2018 May; 293(21):8077-8088. PubMed ID: 29622675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase released from mesenchymal stem cells activates integrin beta1/HIF-2alpha/Flk-1 signaling and promotes endothelial cell migration and angiogenesis.
    Hu X; Zhang L; Jin J; Zhu W; Xu Y; Wu Y; Wang Y; Chen H; Webster KA; Chen H; Yu H; Wang J
    Stem Cells; 2015 Jun; 33(6):1850-1862. PubMed ID: 25754303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brag2 differentially regulates β1- and β3-integrin-dependent adhesion in endothelial cells and is involved in developmental and pathological angiogenesis.
    Manavski Y; Carmona G; Bennewitz K; Tang Z; Zhang F; Sakurai A; Zeiher AM; Gutkind JS; Li X; Kroll J; Dimmeler S; Chavakis E
    Basic Res Cardiol; 2014 Mar; 109(2):404. PubMed ID: 24522833
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms of the angiogenic effects of low-energy shock wave therapy: roles of mechanotransduction.
    Hatanaka K; Ito K; Shindo T; Kagaya Y; Ogata T; Eguchi K; Kurosawa R; Shimokawa H
    Am J Physiol Cell Physiol; 2016 Sep; 311(3):C378-85. PubMed ID: 27413171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orphan nuclear receptor TR3/Nur77 differentially regulates the expression of integrins in angiogenesis.
    Ye T; Peng J; Liu X; Hou S; Niu G; Li Y; Zeng H; Zhao D
    Microvasc Res; 2019 Mar; 122():22-33. PubMed ID: 30391133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Cell Migration and β1 Integrin Trafficking by the Endosomal Adaptor GGA3.
    Ratcliffe CD; Sahgal P; Parachoniak CA; Ivaska J; Park M
    Traffic; 2016 Jun; 17(6):670-88. PubMed ID: 26935970
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorting nexin 17 prevents lysosomal degradation of β1 integrins by binding to the β1-integrin tail.
    Böttcher RT; Stremmel C; Meves A; Meyer H; Widmaier M; Tseng HY; Fässler R
    Nat Cell Biol; 2012 May; 14(6):584-92. PubMed ID: 22561348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells.
    Ao Z; Yu S; Qian P; Gao W; Guo R; Dong X; Xu J; Zhang R; Jiang C; Ji F; Qian G
    Biomed Pharmacother; 2017 Mar; 87():539-547. PubMed ID: 28081464
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The small GTPase Rab5c is a key regulator of trafficking of the CD93/Multimerin-2/β1 integrin complex in endothelial cell adhesion and migration.
    Barbera S; Nardi F; Elia I; Realini G; Lugano R; Santucci A; Tosi GM; Dimberg A; Galvagni F; Orlandini M
    Cell Commun Signal; 2019 May; 17(1):55. PubMed ID: 31138217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA interference-mediated silencing of aquaporin (AQP)-5 hinders angiogenesis of colorectal tumor by suppressing the production of vascular endothelial growth factor.
    Wang W; Li Q; Yang T; Li D; Ding F; Sun H; Bai G
    Neoplasma; 2018; 65(1):55-65. PubMed ID: 29322789
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SNX9, SNX18 and SNX33 are required for progression through and completion of mitosis.
    Ma MP; Chircop M
    J Cell Sci; 2012 Sep; 125(Pt 18):4372-82. PubMed ID: 22718350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sorting nexin 9 negatively regulates invadopodia formation and function in cancer cells.
    Bendris N; Stearns CJ; Reis CR; Rodriguez-Canales J; Liu H; Witkiewicz AW; Schmid SL
    J Cell Sci; 2016 Jul; 129(14):2804-16. PubMed ID: 27278018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of β1 integrin-Klf2-mediated angiogenesis by CCM proteins.
    Renz M; Otten C; Faurobert E; Rudolph F; Zhu Y; Boulday G; Duchene J; Mickoleit M; Dietrich AC; Ramspacher C; Steed E; Manet-Dupé S; Benz A; Hassel D; Vermot J; Huisken J; Tournier-Lasserve E; Felbor U; Sure U; Albiges-Rizo C; Abdelilah-Seyfried S
    Dev Cell; 2015 Jan; 32(2):181-90. PubMed ID: 25625207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of KITENIN on tumor angiogenesis and lymphangiogenesis in colorectal cancer.
    Oh HH; Park KJ; Kim N; Park SY; Park YL; Oak CY; Myung DS; Cho SB; Lee WS; Kim KK; Joo YE
    Oncol Rep; 2016 Jan; 35(1):253-60. PubMed ID: 26496979
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DDA suppresses angiogenesis and tumor growth of colorectal cancer in vivo through decreasing VEGFR2 signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Oncotarget; 2016 Sep; 7(39):63124-63137. PubMed ID: 27517319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Role of Agrin in Maintaining the Stability of Vascular Endothelial Growth Factor Receptor-2 during Tumor Angiogenesis.
    Njah K; Chakraborty S; Qiu B; Arumugam S; Raju A; Pobbati AV; Lakshmanan M; Tergaonkar V; Thibault G; Wang X; Hong W
    Cell Rep; 2019 Jul; 28(4):949-965.e7. PubMed ID: 31340156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CXCL5 induces tumor angiogenesis via enhancing the expression of FOXD1 mediated by the AKT/NF-κB pathway in colorectal cancer.
    Chen C; Xu ZQ; Zong YP; Ou BC; Shen XH; Feng H; Zheng MH; Zhao JK; Lu AG
    Cell Death Dis; 2019 Feb; 10(3):178. PubMed ID: 30792394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Broussonin A- and B-mediated inhibition of angiogenesis by blockade of VEGFR-2 signalling pathways and integrin β1 expression.
    Kim JH; Kim S; Han S; Ahn EK; Cho YR; Jeong W; Kim SJ; Bae GU; Oh JS; Seo DW
    J Cell Mol Med; 2022 Feb; 26(4):1194-1205. PubMed ID: 34994065
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiogenesis by a tenascin-c peptide which is capable of activating beta1-integrins.
    Saito Y; Shiota Y; Nishisaka M; Owaki T; Shimamura M; Fukai F
    Biol Pharm Bull; 2008 May; 31(5):1003-7. PubMed ID: 18451535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.